US › Healthcare

Spectral AI Inc. (MDAI)

US · Healthcare · Medical Devices

$1.59+2.58%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$3.5M

Revenue YoY

-30.4%

Net profit

$-4.2M

EPS

$-0.13

EPS estimate

$-0.14

Net margin

-118.5%

EPS came in at -0.13 against a street estimate of -0.14 — a beat of 7.1%.

Key statistics

Market cap

$51.5M

Forward P/E

52.4

P/B

26.08

Book value

$-0.38

EPS (TTM)

$-0.32

52-week high

$2.97

52-week low

$1.18

50-day MA

$1.64

200-day MA

$1.70

Beta

1.18

Analyst view

Analysts rate Spectral AI Inc. a strong buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $5.12.

Shareholding

Insiders

12.93%

Institutions

19.60%

Largest institutional holders

Fund	Stake
Highlander Partners, L.P.	2.80%
Vanguard Capital Management, LLC	2.26%
Geode Capital Management, LLC	0.94%
Jane Street Group LLC	0.69%
Bridgeway Capital Management, LLC	0.62%
Vanguard Fiduciary Trust Co	0.44%
BlackRock Inc	0.38%
University Of Texas Investment Mgmt Co	0.38%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Spectral AI Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.